• Journal of Animal Science and Technology
• /
• 제65권5호
• /
• pp.895-911
• /
• 2023

Processed meat products play a vital role in our daily dietary intake due to their rich protein content and the inherent convenience they offer. However, they often contain synthetic additives and ingredients that may pose health risks when taken excessively. This review explores strategies to improve meat product quality, focusing on three key approaches: substituting synthetic additives, reducing the ingredients potentially harmful when overconsumed like salt and animal fat, and boosting nutritional value. To replace synthetic additives, natural sources like celery and beet powders, as well as atmospheric cold plasma treatment, have been considered. However, for phosphates, the use of organic alternatives is limited due to the low phosphate content in natural substances. Thus, dietary fiber has been used to replicate phosphate functions by enhancing water retention and emulsion stability in meat products. Reducing the excessive salt and animal fat has garnered attention. Plant polysaccharides interact with water, fat, and proteins, improving gel formation and water retention, and enabling the development of low-salt and low-fat products. Replacing saturated fats with vegetable oils is also an option, but it requires techniques like Pickering emulsion or encapsulation to maintain product quality. These strategies aim to reduce or replace synthetic additives and ingredients that can potentially harm health. Dietary fiber offers numerous health benefits, including gut health improvement, calorie reduction, and blood glucose and lipid level regulation. Natural plant extracts not only enhance oxidative stability but also reduce potential carcinogens as antioxidants. Controlling protein and lipid bioavailability is also considered, especially for specific consumer groups like infants, the elderly, and individuals engaged in physical training with dietary management. Future research should explore the full potential of dietary fiber, encompassing synthetic additive substitution, salt and animal fat reduction, and nutritional enhancement. Additionally, optimal sources and dosages of polysaccharides should be determined, considering their distinct properties in interactions with water, proteins, and fats. This holistic approach holds promise for improving meat product quality with minimal processing.

• Nutrition Research and Practice
• /
• 제14권6호
• /
• pp.580-592
• /
• 2020

BACKGROUND/OBJECTIVES: The present study aimed to further investigate the potential health beneficial effects of long-term seaweed supplementation on lipid metabolism and hepatic functions in DIO mice. MATERIALS/METHODS: Four brown seaweeds (Undaria pinnatifida [UP], Laminaria japonica [LJ], Sargassum fulvellum [SF], or Hizikia fusiforme [HF]) were added to a high fat diet (HFD) at a 5% ratio and supplemented to C57BL/6N mice for 16 weeks. Triglycerides (TGs) and total cholesterol (TC) in the liver, feces, and plasma were measured. Fecal bile acid (BA) levels in feces were monitored. Hepatic insulin signaling- and lipogenesis-related proteins were evaluated by Western blot analysis. RESULTS: Fasting blood glucose levels were significantly reduced in the LJ, SF, and HF groups compared to the HFD group by the end of 16-week feeding period. Plasma TG levels and hepatic lipid accumulation were significantly reduced in all 4 seaweed supplemented groups, whereas plasma TC levels were only suppressed in the UP and HF groups compared to the HFD group. Fecal BA levels were significantly elevated by UP, LJ, and SF supplementation compared to HFD feeding only. Lastly, regarding hepatic insulin signaling-related proteins, phosphorylation of 5'-AMP-activated protein kinase was significantly up-regulated by all 4 types of seaweed, whereas phosphorylation of protein kinase B was up-regulated only in the SF and HF groups. Lipogenesis-related proteins in the liver were effectively down-regulated by HF supplementation in DIO mice. CONCLUSIONS: Brown seaweed consumption showed hypotriglyceridemic effects in the prolonged DIO mouse model. Specifically, combinatory regulation of BA excretion and lipogenesis-related proteins in the liver by seaweed supplementation contributed to the reduction of plasma and hepatic TG levels, which inhibited hyperglycemia in DIO mice. Thus, the discrepant and species-specific functions of brown seaweeds provide novel insights for the selection of future targets for therapeutic agents.

• The Korean Journal of Physiology and Pharmacology
• /
• 제21권5호
• /
• pp.519-529
• /
• 2017

Sodium butyrate (SB) has various metabolic actions. However, its effect on dipeptidyl peptidase 4 (DPP-4) needs to be studied further. We aimed to evaluate the metabolic actions of SB, considering its physiologically relevant concentration. We evaluated the effect of SB on regulation of DPP-4 and its other metabolic actions, both in vitro (HepG2 cells and mouse mesangial cells) and in vivo (high fat diet [HFD]-induced obese mice). Ten-week HFD-induced obese C57BL/6J mice were subjected to SB treatment by adding SB to HFD which was maintained for an additional 16 weeks. In HepG2 cells, SB suppressed DPP-4 activity and expression at sub-molar concentrations, whereas it increased DPP-4 activity at a concentration of $1,000{\mu}M$. In HFD-induced obese mice, SB decreased blood glucose, serum levels of insulin and $IL-1{\beta}$, and DPP-4 activity, and suppressed the increase in body weight. On the contrary, various tissues including liver, kidney, and peripheral blood cells showed variable responses of DPP-4 to SB. Especially in the kidney, although DPP-4 activity was decreased by SB in HFD-induced obese mice, it caused an increase in mRNA expression of $TNF-{\alpha}$, IL-6, and $IL-1{\beta}$. The pro-inflammatory actions of SB in the kidney of HFD-induced obese mice were recapitulated by cultured mesangial cell experiments, in which SB stimulated the secretion of several cytokines from cells. Our results showed that SB has differential actions according to its treatment dose and the type of cells and tissues. Thus, further studies are required to evaluate its therapeutic relevance in metabolic diseases including diabetes and obesity.

• Asian-Australasian Journal of Animal Sciences
• /
• 제28권6호
• /
• pp.870-875
• /
• 2015

The purpose of this study was to investigate the alternative splicing in equine cordon-bleu WH2 repeat protein-like 1 (COBLL1) gene that was identified in horse muscle and blood leukocytes, and to predict functional consequences of alternative splicing by bioinformatics analysis. In a previous study, RNA-seq analysis predicted the presence of alternative spliced isoforms of equine COBLL1, namely COBLL1a as a long form and COBLL1b as a short form. In this study, we validated two isoforms of COBLL1 transcripts in horse tissues by the real-time polymerase chain reaction, and cloned them for Sanger sequencing. The sequencing results showed that the alternative splicing occurs at exon 9. Prediction of protein structure of these isoforms revealed three putative phosphorylation sites at the amino acid sequences encoded in exon 9, which is deleted in COBLL1b. In expression analysis, it was found that COBLL1b was expressed ubiquitously and equivalently in all the analyzed tissues, whereas COBLL1a showed strong expression in kidney, spinal cord and lung, moderate expression in heart and skeletal muscle, and low expression in thyroid and colon. In muscle, both COBLL1a and COBLL1b expression decreased after exercise. It is assumed that the regulation of COBLL1 expression may be important for regulating glucose level or switching of energy source, possibly through an insulin signaling pathway, in muscle after exercise. Further study is warranted to reveal the functional importance of COBLL1 on athletic performance in race horses.

• 생명과학회지
• /
• 제17권12호
• /
• pp.1709-1716
• /
• 2007

본 연구에서는 몇 가지 암세포를 대상으로 마늘 열수추출물(WEAS)의 항암활성을 조사하였으며, 비교적 높은 감수성을 보인 백혈병세포를 대상으로 세포증식억제가 apoptosis 유도와 연관성이 있음을 제시하였다. WEAS에 의한 U937 세포의 apoptosis 유도는 세포주기 G2/M arrest와 연관성이 있었으며, 다양한 apoptosis조절 유전자들의 발현 변화를 동반하였음을 확인하였다. 이러한 apoptosis조절 인자들의 발현변화는 미토콘드리아 막 전위의 소실과 연관성이 있었으며, WEAS에 의한 암세포의 G2/M arrest에 의한 apoptosis 유발에 ROS가 중요한 조절자로 작용함을 알 수 있었다.

• 한국식품영양과학회지
• /
• 제42권3호
• /
• pp.325-334
• /
• 2013

솔잎착즙액과 솔잎발효액의 항산화활성을 분석하기 위하여 총 페놀함량, DPPH 라디칼 소거능, 총 항산화능, $ORAC_{ROO{\cdot}}$ 활성, CAC 활성을 분석하였고, 항유전독성을 분석하기 위하여 DNA 손상 억제능을 분석하였으며, 항당뇨효과와 항고혈압 효과를 분석하기 위하여 각각 ${\alpha}$-glucosidase 및 ACE 저해활성을 분석하였다. 총 페놀 함량은 솔잎착즙액(17.3 mg GAE/g)이 솔잎발효액(4.6 mg GAE/g)보다 유의적으로 3.7배 높았으며, 이는 발효가 진행됨에 따라 페놀 성분이 침전된 결과로 보인다. DPPH 라디칼 소거능, 총 항산화능 및 $ORAC_{ROO{\cdot}}$ 활성은 솔잎착즙액이 솔잎발효액 보다 유의적으로 높았다. 즉 1 mg/mL 수준에서 솔잎착즙액과 솔잎발효액의 DPPH 라디칼 소거능은 각각 33.3%, 21.4%로 나타났고, $60{\sim}530{\mu}g/mL$ 농도에서 솔잎착즙액이 솔잎발효액보다 유의적으로 높은 총 항산화능을 나타내었으며, $2{\sim}100{\mu}g/mL$ 농도에서 솔잎착즙액이 솔잎발효액보다 유의적으로 높은 $ORAC_{ROO{\cdot}}$ 활성을 나타내었다. 솔잎착즙액과 솔잎발효액의 CAC 활성은 AAPH 처리군보다 솔잎착즙액 및 솔잎발효액 처리군의 CAC 활성이 농도 의존적으로 증가하였으며, $50{\mu}g/mL$ 농도를 제외하고 두 그룹 간의 유의적인 차이는 나타나지 않았다. 솔잎착즙액과 솔잎발효액의 항산화활성의 상관관계는 총 항산화능과 DPPH 라디칼소거능(r=0.836, p=0.000) 및 ORAC assay(r=0.918, p=0.000) 간의 높은 양의 상관관계가 나타났을 뿐만 아니라 DPPH 라디칼 소거능과 ORAC assay(r=0.909, p=0.000) 간에도 높은 양의 상관관계가 나타나 솔잎착즙액과 솔잎발효액의 높은 항산화활성을 추측할 수 있었다. $H_2O_2$로 유도된 산화적 스트레스에 대한 DNA 손상 억제능은 솔잎착즙액과 솔잎발효액에서 농도의존적으로 증가하였으며, $50{\mu}g/mL$ 농도에서 솔잎발효액이 솔잎착즙액보다 더 높은 경향을 나타내었다. 솔잎착즙액과 솔잎발효액의 항당뇨 효과를 알아보기 위하여 ${\alpha}$-glucosidase 억제능을 실험한 결과 희석배율이 증가할수록 솔잎발효액의 ${\alpha}$-glucosidase 억제능은 급격히 감소하는 반면, 솔잎착즙액은 솔잎발효액보다 높은 활성을 유지하는 것으로 나타났다. 항고혈압 효과 분석을 위한 ACE 저해활성은 2배 희석 시 솔잎착즙액 87.1%, 솔잎발효액 60.0%로 솔잎착즙액의 ACE 저해활성이 높은 경향을 나타내었다. 본 연구를 통해 솔잎착즙액의 다양한 생리활성을 평가하고자 하였으며, 발효가 이러한 생리활성에 미치는 영향을 분석하고자 하였다. 본 연구에서 2년간 발효한 솔잎발효액만을 분석하였고, 발효기간에 따른 활성의 변화를 평가하지 못한 제한점이 있으나 본 연구의 결과는 지금까지 연구가 미흡했던 솔잎착즙액의 생리활성을 보고함으로써 솔잎을 활용한 기능성 소개개발에 유용한 자료로 제안될 수 있을 것이다. 또한 향후 연구에서 솔잎착즙액의 기능성을 증대시킬 수 있는 발효과정에 대한 연구가 수행되어야 할 것이다.

• 치위생과학회지
• /
• 제12권5호
• /
• pp.493-502
• /
• 2012

본 연구는 제2형 당뇨병 환자가 인식하고 있는 구강건강 문제를 파악하고, 당화혈색소와 주관적 구강건강상태와의 연관성을 제시함으로써 당뇨병 환자의 전신 및 구강건강증진을 위한 기초자료를 제시하고자 시행하였다. 2012년 1월 9일부터 2012년 3월 9일까지 만 40세 이상 제2형 당뇨병을 가진 환자 174명에게 설문지 조사와 $In2it^{TM}$을 이용하여 당화혈색소를 측정한 결과 다음과 같은 결론을 얻었다. 1. 연구대상자의 구강건강문제를 파악한 결과 구강점막질환 증상 중 '입 안 점막에 염증이 있다'와 '입 안 점막이 아프다', 치주질환 증상 중 '칫솔질 시 잇몸에서 피가 난다', 구강건조증 증상 중 '평상시 내 입 안은 마른다고 느낀다'를 가장 많이 인식하는 것으로 나타났다. 2. 일반적 특성에 따라 주관적 구강건강상태를 분석한 결과, 특히 당뇨병 유병기간이 길수록 입안점막질환과 치주질환의 증상 및 구강건조증 증상을 더 많이 인식하는 것으로 나타났다(p<0.05). 3. 혈당 조절을 위한 건강행동에 따라 당화혈색소 수준을 분석한 결과, 규칙적인 식사를 잘 실천하는 집단에서 당화혈색소 수준이 더 낮은 것으로 나타났다(p<0.01). 4. 주관적 구강건강상태에 따라 당화혈색소 수준을 분석한 결과, '혀에 타는 듯한 느낌이 있다', '칫솔질 시 잇몸에서 피가 난다', '잇몸이 치아 뿌리 쪽으로 내려갔다' 및 '입에서 나쁜 냄새가 난다'를 인식한 집단에서 당화혈색소 수준이 더 높았다(p<0.05). 또한 구강건조증 증상 중 '나는 목이 말라 자다가 일어나 물을 마신다'에 응답한 집단에서 당화혈색소 수준이 더 높았다(p<0.05). 특히 다중선형회귀분석 결과 치주질환 증상은 당화혈색소와 3번째로 강한 연관성을 보인 요인으로 나타났다. 이상의 결과로 볼 때 혈당조절 정도는 다양한 구강건강문제와 관련성이 있으므로 당뇨병 환자를 대상으로 구강관리 프로그램의 적용을 더욱 강화하고, 의료인력의 협진을 통해 구강 내 당뇨합병증을 최대한 감소시켜야 할 것이다.